Skip to main content
Adrienne Phillips, MD, Oncology, New York, NY, New York-Presbyterian Hospital

AdrienneAlisePhillipsMD

Oncology New York, NY

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Dr. Phillips is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Phillips' full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusFellowship, Hematology/Oncology, 2004 - 2007
  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusResidency, Internal Medicine, 2001 - 2004
  • Brown University
    Brown UniversityClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2003 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
    Adrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
    Adrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
    Adrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • 4 Health Problems African-American Women Face
    4 Health Problems African-American Women FaceFebruary 8th, 2018
  • Expert Sheds Light on Lesser-Known T-cell Lymphoma Subtypes
    Expert Sheds Light on Lesser-Known T-cell Lymphoma SubtypesJune 22nd, 2017
  • Mogamulizumab Offers Option for Rare Relapsed, Refractory T-cell Leukemia/Lymphoma
    Mogamulizumab Offers Option for Rare Relapsed, Refractory T-cell Leukemia/LymphomaJune 23rd, 2016
  • Join now to see all

Hospital Affiliations